208 results
Page 3 of 11
8-K
EX-1.1
ag3vok rha8a9soi
22 Apr 21
NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock
9:33am
424B5
wforfxmet
21 Apr 21
Prospectus supplement for primary offering
4:03pm
8-K
EX-10.1
ur2b4 pso
2 Dec 20
NeuBase Therapeutics Announces Appointment of Curt Bradshaw, Ph.D. as Chief Scientific Officer
9:57am
8-K
EX-10.1
jns9x7u
11 Sep 20
Other Events
5:06pm
8-K
EX-10.1
xdfhmhw 09yk
28 Jul 20
NeuBase Therapeutics Strengthens Senior Management Team with Appointment of Industry Veteran William Mann, Ph.D., MBA as Chief Operating Officer
8:16am
424B5
ln9nvdcqil tx
29 Apr 20
Prospectus supplement for primary offering
4:21pm
8-K
EX-1.1
ahfu ardhbip2ba
29 Apr 20
NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock
12:00am
424B5
z7wo9om3d58poknfjt9
27 Apr 20
Prospectus supplement for primary offering
4:23pm
8-K/A
EX-99.2
35wwi 7d7
26 Mar 20
Financial Statements and Exhibits
5:15pm
S-8
EX-4.6
a6c1chmmkkyvh2k
16 Aug 19
Registration of securities for employees
5:02pm